Oxazolidinones: a review (Q28373208)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10718097%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

review article

1 reference

title

Oxazolidinones: a review (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10718097%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

language of work or name

English

0 references

publication date

1 January 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10718097%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10718097%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

volume

59

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10718097%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10718097%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

page(s)

7-16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10718097%20AND%20SRC:MED&resulttype=core&format=json

In vitro and in vivo antistaphylococcal activities of L-695,256, a carbapenem with high affinity for the penicillin-binding protein PBP 2a.

4 November 2019

cites work

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F00003495-200059010-00002

Mechanism of action of DuP 721: inhibition of an early event during initiation of protein synthesis

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F00003495-200059010-00002

QUANTITATIVE ACTION OF PENICILLIN INHIBITOR FROM PENICILLIN-RESISTANT STRAINS OF STAPHYLOCOCCI.

21 January 2018

1 reference

12 December 2020

Prevalence of antimicrobial resistance among respiratory tract isolates of Streptococcus pneumoniae in North America: 1997 results from the SENTRY antimicrobial surveillance program

1 reference

12 December 2020

Emerging multiply resistant enterococci among clinical isolates. I. Prevalence data from 97 medical center surveillance study in the United States. Enterococcus Study Group

1 reference

12 December 2020

Bacteremia due to viridans streptococci in neutropenic patients: a review

1 reference

12 December 2020

Disk diffusion test interpretive criteria and quality control recommendations for testing linezolid (U-100766) and eperezolid (U-100592) with commercially prepared reagents

1 reference

12 December 2020

In vitro activities of the oxazolidinone antibiotics U-100592 and U-100766 against Staphylococcus aureus and coagulase-negative Staphylococcus species

1 reference

12 December 2020

In vitro activities of oxazolidinones U-100592 and U-100766 against penicillin-resistant and cephalosporin-resistant strains of Streptococcus pneumoniae

1 reference

12 December 2020

Methicillin-resistant Staphylococcus aureus in U.S. hospitals, 1975-1991

1 reference

12 December 2020

In vitro antibiotic synergy against Flavobacterium meningosepticum: implications for therapeutic options

1 reference

12 December 2020

Ribosomes from an oxazolidinone-resistant mutant confer resistance to eperezolid in a Staphylococcus aureus cell-free transcription-translation assay

1 reference

12 December 2020

In vitro activity and spectrum of LY333328, a novel glycopeptide derivative.

1 reference

12 December 2020

In vitro activity of linezolid and eperezolid, two novel oxazolidinone antimicrobial agents, against anaerobic bacteria

1 reference

12 December 2020

Effect of quinupristin/dalfopristin on the outcome of vancomycin- resistant Enterococcus faecium bacteraemia: comparison with a control cohort

1 reference

12 December 2020

Activities of RPR 106972 (a new oral streptogramin), cefditoren (a new oral cephalosporin), two new oxazolidinones (U-100592 and U-100766), and other oral and parenteral agents against 203 penicillin-susceptible and -resistant pneumococci.

1 reference

12 December 2020

Activity and mechanism of action of DuP 105 and DuP 721, new oxazolidinone compounds

1 reference

12 December 2020

Secular trends in nosocomial primary bloodstream infections in the United States, 1980-1989. National Nosocomial Infections Surveillance System

1 reference

12 December 2020

Oxazolidinones, a new class of synthetic antibacterial agents: in vitro and in vivo activities of DuP 105 and DuP 721

1 reference

12 December 2020

Oxazolidinones: new antibacterial agents

1 reference

12 December 2020

The oxazolidinone eperezolid binds to the 50S ribosomal subunit and competes with binding of chloramphenicol and lincomycin

1 reference

12 December 2020

Vancomycin-resistant enterococci

1 reference

12 December 2020

Comparative in vitro activities and postantibiotic effects of the oxazolidinone compounds eperezolid (PNU-100592) and linezolid (PNU-100766) versus vancomycin against Staphylococcus aureus, coagulase-negative staphylococci, Enterococcus faecalis, an

1 reference

12 December 2020

In vivo activities of U-100592 and U-100766, novel oxazolidinone antimicrobial agents, against experimental bacterial infections.

1 reference

12 December 2020

A novel antimicrobial agent joins the battle against resistant bacteria

1 reference

12 December 2020

Daptomycin disrupts membrane potential in growing Staphylococcus aureus

1 reference

12 December 2020

Oxazolidinones, a new class of synthetic antituberculosis agent in vitro and in vivo activities of DuP-721 against Mycobacterium tuberculosis

1 reference

12 December 2020

In-vitro activity of oxazolidinones against Mycobacterium avium Complex

1 reference

12 December 2020

Mechanism of action of oxazolidinones: effects of linezolid and eperezolid on translation reactions

1 reference

12 December 2020

The oxazolidinone linezolid inhibits initiation of protein synthesis in bacteria

1 reference

12 December 2020

Emergence of vancomycin resistance in coagulase-negative staphylococci

1 reference

12 December 2020

In vitro activities of U-100592 and U-100766, novel oxazolidinone antibacterial agents

1 reference

12 December 2020

Susceptibilities of Legionella spp. to newer antimicrobials in vitro

1 reference

12 December 2020

Bacterial pathogens isolated from patients with bloodstream infection: frequencies of occurrence and antimicrobial susceptibility patterns from the SENTRY antimicrobial surveillance program (United States and Canada, 1997).

1 reference

12 December 2020

Antimicrobial Activity of SCH 27899, Oligosaccharide Member of the Everninomycin Class with a Wide Gram-Positive Spectrum.

1 reference

12 December 2020

Comparative In Vitro and Bactericidal Activity of Oxazolidinone Antibiotics Against Multidrug-Resistant Enterococci

1 reference

12 December 2020

Synthesis and antibacterial activity of U-100592 and U-100766, two oxazolidinone antibacterial agents for the potential treatment of multidrug-resistant gram-positive bacterial infections

1 reference

12 December 2020

In vitro activities of two novel oxazolidinones (U100592 and U100766), a new fluoroquinolone (trovafloxacin), and dalfopristin-quinupristin against Staphylococcus aureus and Staphylococcus epidermidis

1 reference

12 December 2020

In vitro antimicrobial activities and spectra of U-100592 and U-100766, two novel fluorinated oxazolidinones

1 reference

12 December 2020

Staphylococcus aureus and coagulase-negative staphylococci from blood stream infections: frequency of occurrence, antimicrobial susceptibility, and molecular (mecA) characterization of oxacillin resistance in the SCOPE program

1 reference

12 December 2020

The pharmacologic and bacteriologic properties of oxazolidinones, a new class of synthetic antimicrobials.

1 reference

12 December 2020

In vitro activities in new oxazolidinone antimicrobial agents against enterococci

1 reference

12 December 2020

Identification of a novel oxazolidinone (U-100480) with potent antimycobacterial activity

1 reference

12 December 2020

Activities of several novel oxazolidinones against Mycobacterium tuberculosis in a murine model

1 reference

12 December 2020

In vitro activities of oxazolidinone compounds U100592 and U100766 against Staphylococcus aureus and Staphylococcus epidermidis.

1 reference

12 December 2020

Update: Staphylococcus aureus with reduced susceptibility to vancomycin--United States, 1997

1 reference

12 December 2020

In vitro activities of an investigational quinolone, glycylcycline, glycopeptide, streptogramin, and oxazolidinone tested alone and in combinations against vancomycin-resistant Enterococcus faecium

1 reference

12 December 2020